4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000149
Chairperson & CEO sold 9,500 shares at an average $473.55 ($4,498,753)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-24 | Sale : show line 2 in the form 10b5-1 | −640 | $469.74 | $300,631 | 333,303 | I |
| 2026-09-24 | Sale : show line 3 in the form 10b5-1 | −2,603 | $470.63 | $1,225,045 | 330,700 | I |
| 2026-09-24 | Sale : show line 4 in the form 10b5-1 | −2,160 | $471.77 | $1,019,026 | 328,540 | I |
| 2026-09-24 | Sale : show line 5 in the form 10b5-1 | −580 | $472.73 | $274,184 | 327,960 | I |
| 2026-09-24 | Sale : show line 6 in the form 10b5-1 | −437 | $474.01 | $207,141 | 327,523 | I |
| 2026-09-24 | Sale : show line 7 in the form 10b5-1 | −320 | $475.35 | $152,114 | 327,203 | I |
| 2026-09-24 | Sale : show line 8 in the form 10b5-1 | −280 | $476.51 | $133,424 | 326,923 | I |
| Open-market sales · 9,500 sh · avg $473.55 · $4,498,753 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-24 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −9,500 | 366,410 | I |
Loading xslF345X06/primarydocument.xml…